Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Graft vs Host Disease (approved 2021)
Autoimmune Diseases (Phase 1)
Biological Availability (Phase 1)
Bronchiolitis (Phase 2)
Bronchiolitis Obliterans (Phase 2)
Colorectal Neoplasms (Early Phase 1)
Drug Interactions (Phase 1)
Fibrosis (Phase 1)
Graft vs Host Disease (Phase 3)
Healthy Volunteers (Early Phase 1)
Idiopathic Pulmonary Fibrosis (Phase 2)
Kidney Failure, Chronic (Phase 1)
Liver Diseases (Phase 1)
Lung Diseases (Phase 2)
Lung Transplantation (Phase 3)
Multiple Myeloma (Phase 1/Phase 2)
Neoplasms (Early Phase 1)
Psoriasis (Phase 2)
Renal Insufficiency, Chronic (Phase 1)
Scleroderma, Diffuse (Phase 2)
Sclerosis (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue